venBio Global Strategic Fund IV, L.P.
CIK 1862109 · View on SEC EDGAR ↗
First SEC filing: Aug. 4, 2026 · Latest: Aug. 4, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2026 | ATTO | P | 382,352 | $17.00 | $6,499,984 | 4,181,367 Direct | +10.06% | Acquired | 18.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 6, 2026 | ATTO | Series A Preferred Stock | Common Stock (2,311,870) | — | — | 21,477,273 | Disposed |
| Aug. 6, 2026 | ATTO | Series B Preferred Stock | Common Stock (821,998) | — | — | 7,636,362 | Disposed |
| Aug. 6, 2026 | ATTO | Series C Preferred Stock | Common Stock (665,147) | — | — | 6,179,219 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.